Section 156: Pet Therapy and Animal-Assisted Interventions in CBS/PSP

Section 156: Pet Therapy and Animal-Assisted Interventions in CBS/PSP

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 156: Pet Therapy and Animal-Assisted Interventions in CBS/PSP</th>
</tr>
<tr>
<td class="label">Symptom Domain</td>
<td>PD Evidence</td>
</tr>
<tr>
<td class="label">Gait/balance</td>
<td>Moderate benefit</td>
</tr>
<tr>
<td class="label">Depression/anxiety</td>
<td>Significant benefit</td>
</tr>
<tr>
<td class="label">Quality of life</td>
<td>Significant benefit</td>
</tr>
<tr>
<td class="label">Social function</td>
<td>Moderate benefit</td>
</tr>
<tr>
<td class="label">Motor engagement</td>
<td>Moderate benefit</td>
</tr>
<tr>
<td class="label">Organization</td>
<td>Focus</td>
</tr>
<tr>
<td class="label">Canine Companions for Independence</td>
<td>Mobility, psychiatric</td>
</tr>
<tr>
<td class="label">Paws with a Cause</td>
<td>Mobility, hearing</td>
</tr>
<tr>
<td class="label">Assistance Dogs International</td>
<td>Various</td>
</tr>
<tr>
<td class="label">Local independent trainers</td>
<td>Custom training</td>
</tr>
<tr>
<td class="label">Expense Category</td>
<td>Annual Cost</td>
</tr>
<tr>
<td class="label">Food</td>
<td>$500-$1,000</td>
</tr>
<tr>
<td class="label">Veterinary care</td>
<td>$500-$1,500</td>
</tr>
<tr>
<td class="label">Grooming</td>
<td>$300-$600</td>
</tr>
<tr>
<td class="label"

Section 156: Pet Therapy and Animal-Assisted Interventions in CBS/PSP

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 156: Pet Therapy and Animal-Assisted Interventions in CBS/PSP</th>
</tr>
<tr>
<td class="label">Symptom Domain</td>
<td>PD Evidence</td>
</tr>
<tr>
<td class="label">Gait/balance</td>
<td>Moderate benefit</td>
</tr>
<tr>
<td class="label">Depression/anxiety</td>
<td>Significant benefit</td>
</tr>
<tr>
<td class="label">Quality of life</td>
<td>Significant benefit</td>
</tr>
<tr>
<td class="label">Social function</td>
<td>Moderate benefit</td>
</tr>
<tr>
<td class="label">Motor engagement</td>
<td>Moderate benefit</td>
</tr>
<tr>
<td class="label">Organization</td>
<td>Focus</td>
</tr>
<tr>
<td class="label">Canine Companions for Independence</td>
<td>Mobility, psychiatric</td>
</tr>
<tr>
<td class="label">Paws with a Cause</td>
<td>Mobility, hearing</td>
</tr>
<tr>
<td class="label">Assistance Dogs International</td>
<td>Various</td>
</tr>
<tr>
<td class="label">Local independent trainers</td>
<td>Custom training</td>
</tr>
<tr>
<td class="label">Expense Category</td>
<td>Annual Cost</td>
</tr>
<tr>
<td class="label">Food</td>
<td>$500-$1,000</td>
</tr>
<tr>
<td class="label">Veterinary care</td>
<td>$500-$1,500</td>
</tr>
<tr>
<td class="label">Grooming</td>
<td>$300-$600</td>
</tr>
<tr>
<td class="label">Supplies (bed, leash, etc.)</td>
<td>$200-$500</td>
</tr>
<tr>
<td class="label">Total</td>
<td>$1,500-$3,600</td>
</tr>
</table>

Animal-assisted interventions (AAI) represent a growing field of therapeutic support for individuals with neurodegenerative disorders, including [Corticobasal Syndrome](/diseases/corticobasal-degeneration) (CBS) and [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy) (PSP). These atypical parkinsonian disorders present unique challenges—progressive motor impairment, cognitive decline, balance dysfunction, and emotional distress—that can be partially addressed through structured animal interactions. While research specifically targeting [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy) remains limited, substantial evidence from [Parkinson's disease](/diseases/parkinsons-disease) studies and broader neurological populations provides a strong foundation for recommending animal-assisted therapies in these conditions.

Animal-assisted interventions encompass a spectrum of programs ranging from formal service dog training for mobility assistance to informal therapy animal visits providing emotional comfort. The therapeutic value of human-animal bonds has been recognized for millennia, but modern evidence-based practice has formalized these interventions with measurable outcomes[@fine2019]. For CBS/PSP patients—who face progressive loss of independence, communication difficulties, and significant emotional burden—animal-assisted interventions offer complementary support that addresses physical, cognitive, and psychosocial domains simultaneously.

This section provides comprehensive guidance on the types of animal-assisted interventions available, their mechanisms of action, evidence base, practical considerations, and implementation strategies for [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy) patients. The information is designed to help patients, caregivers, and healthcare professionals understand and access these valuable resources.

1. Mechanisms of Action

1.1 Physiological Mechanisms

The therapeutic effects of animal-assisted interventions operate through multiple physiological pathways that are particularly relevant to [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy) symptom profiles.

Neurochemical Effects:

Interaction with animals triggers measurable changes in neurochemistry that can benefit neurological patients. Petting and interacting with animals has been shown to increase oxytocin levels, a peptide associated with social bonding, trust, and stress reduction[@nagasawa2015]. Simultaneously, cortisol—the primary stress hormone—tends to decrease during animal interactions, counteracting the chronic stress that often accompanies progressive neurodegenerative conditions[@odendaal2003].

Dopamine release, critical in Parkinson's and related disorders, may be modulated through animal-assisted activities. The anticipation of animal interaction, the sensory experience of petting, and the emotional engagement all activate reward pathways that involve dopaminergic transmission[@handler2019]. While not a disease-modifying intervention, this dopamine modulation may provide temporary symptomatic benefit.

Cardiovascular Effects:

Studies consistently demonstrate that animal interaction reduces blood pressure and heart rate variability, indicating reduced cardiovascular stress[@friedmann2013]. For CBS/PSP patients—who often experience [autonomic dysfunction](/mechanisms/autonomic-dysfunction-neurodegeneration) including orthostatic hypotension—these cardiovascular benefits may be particularly valuable.

Motor Activation:

Walking with a service dog or engaging with therapy animals provides gentle physical activity that can help maintain mobility. The rhythmic nature of walking, the motivation provided by the animal companion, and the outdoor exposure all contribute to physical engagement that might otherwise be lacking in progressive neurological conditions[@christian2013].

1.2 Psychological Mechanisms

Beyond physiological effects, animal-assisted interventions work through powerful psychological pathways that address the emotional and social challenges of [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy).

Companionship and Reduced Isolation:

Progressive neurological conditions often lead to social withdrawal as mobility limitations and communication difficulties increase. Animals provide unconditional companionship that does not require verbal communication or complex social navigation[@banks2002]. This is particularly valuable for CBS patients with aphasia or PSP patients with dysarthria, who may struggle with verbal social interaction.

Purpose and Motivation:

Caring for an animal provides daily structure and purpose—elements that are often lost as disease progression limits previous activities and roles. The responsibility of feeding, walking, and caring for an animal creates a routine that can combat the [depression](/mechanisms/depression-neurodegeneration) and [apathy](/mechanisms/apathy-motivation-neurodegeneration) common in CBS/PSP[@siegel2003].

Emotional Regulation:

Animals provide consistent emotional support during difficult moments. The non-judgmental presence of an animal offers a safe outlet for emotional expression, whether through verbal processing or simply through physical proximity. This emotional buffering can help manage the anxiety, frustration, and grief associated with progressive neurological decline.

2. Types of Animal-Assisted Interventions

2.1 Service Dogs

Service dogs are individually trained to perform specific tasks that assist persons with disabilities. For [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy) patients, service dogs can be trained to perform mobility-related tasks that address the core motor impairments of these conditions[@wewers2020].

Mobility Assistance Tasks:

• Balance Support: Dogs can be trained to provide physical support during walking, serving as a living cane that adapts to the patient's movements
• Retrieval: Retrieving dropped items, medication, phone, or other needed objects
• Pulling Assistance: Providing counterbalance during transitions (sit to stand, bed to wheelchair)
• Pressure Alert: Some dogs can be trained to respond to freezing of gait or to provide pressure during episodes of retropulsion
• Wall Following: Guiding patients along walls or corridors in low-visibility environments

• Fall Alert: Trained to respond to or predict falls
• Medication Reminders: Providing reminders at scheduled medication times
• Wake/Salert: Helping rouse patients from sleep or alerting caregivers to medical emergencies

Service dog training is intensive and specific. Programs typically require 1-2 years of training, with public access training taking an additional 6-12 months. Organizations such as [Canine Companions for Independence](https://www.canine.org/), [Paws with a Cause](https://www.pawswithacause.org/), and [Guide Dogs for the Blind](https://www.guidedogs.com/) provide service dogs at no cost, though the waiting list can be extensive.

For CBS/PSP patients, the progressive nature of the disease presents unique considerations. Patients should apply for service dogs early in the disease course while they can participate in training. Some organizations offer "task-specific" training for individuals already partnered with dogs.

2.2 Therapy Animals

Therapy animals—typically dogs or cats—visit healthcare facilities, rehabilitation centers, and private homes to provide emotional comfort and therapeutic engagement. Unlike service dogs, therapy animals do not perform specific disability-related tasks but rather provide general therapeutic benefit through presence and interaction[@kruger2006].

Facility-Based Therapy:

Animal-assisted therapy programs in rehabilitation facilities, day programs, and residential care settings provide structured animal visits. These programs are often facilitated by trained handlers and may include specific therapeutic goals such as:

• Increasing verbal interaction during visits
• Encouraging physical activity (walking with animal, throwing ball)
• Providing emotional comfort during therapy sessions
• Facilitating social interaction among patients

Private therapy animal visits can be arranged through organizations or through personal pets that have been evaluated and certified for therapy work. Home visits may be particularly valuable for homebound CBS/PSP patients who cannot access facility-based programs.

Evidence from Neurological Populations:

A systematic review of animal-assisted therapy in neurological rehabilitation found moderate evidence for improving motor function and strong evidence for improving emotional wellbeing and social function[@chen2020]. Studies in [Parkinson's disease](/diseases/parkinsons-disease) demonstrate that animal-assisted therapy can improve gait speed, balance, and quality of life measures[@yount2019].

2.3 Emotional Support Animals

Emotional support animals (ESAs) provide comfort through companionship but are not trained to perform specific tasks. Unlike service dogs, ESAs do not have public access rights under the Americans with Disabilities Act, though they may be protected under housing laws[@americans].

Benefits for CBS/PSP:

While ESAs do not provide the functional assistance of service dogs, the companionship benefit can be significant:

• Reduced loneliness and social isolation
• Increased daily structure and routine
• Consistent emotional support
• Motivational benefit for self-care

ESAs require a letter from a licensed mental health professional stating the need for the animal. Housing protections under the Fair Housing Act allow ESAs in no-pet housing with proper documentation. However, ESAs do not have the public access rights granted to service dogs.

3. Evidence from Parkinson's and Related Studies

3.1 Parkinson's Disease Studies

While direct evidence in [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy) is limited, research in [Parkinson's disease](/diseases/parkinsons-disease) provides the most relevant evidence base due to significant overlap in motor and non-motor symptoms.

Gait and Balance:

A study examining animal-assisted gait training in [Parkinson's disease](/diseases/parkinsons-disease) found that walking with a therapy dog improved gait speed, stride length, and symmetry compared to standard gait training alone[@pashaj2019]. The motivational effect of the animal companion appeared to enhance engagement and performance.

Quality of Life:

Multiple studies demonstrate that animal-assisted interventions improve quality of life measures in [Parkinson's disease](/diseases/parkinsons-disease). A 2021 randomized controlled trial found that 12 weeks of animal-assisted therapy significantly improved Parkinson's Disease Questionnaire-39 (PDQ-39) scores, with particular benefit in domains of emotional wellbeing, social function, and communication[@koda2021].

Depression and Anxiety:

Animal-assisted therapy has shown effectiveness in reducing depression and anxiety in [Parkinson's disease](/diseases/parkinsons-disease). A meta-analysis of animal-assisted interventions for neurological conditions found significant reductions in depressive symptoms, with effects comparable to conventional psychotherapy[@johnson2020].

3.2 Extrapolation to [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy)

The evidence from [Parkinson's disease](/diseases/parkinsons-disease) can be reasonably extrapolated to [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy) based on shared pathophysiology and symptom profiles:

While head-to-head trials in CBS/PSP populations would strengthen the evidence base, the mechanistic similarity and symptom overlap support the recommendation of animal-assisted interventions for these conditions.

4. Benefits for CBS/PSP Specific Domains

4.1 Motor Function Benefits

Gait Improvement:

For CBS/PSP patients with gait dysfunction, animal-assisted walking provides task-specific training that may improve gait quality. The animal provides a rhythmic, motivating focus that can help overcome freezing of gait—a common challenge in PSP[@nonnekes2016]. The physical presence of the animal also provides subtle balance support.

Upper Extremity Function:

Interacting with animals—including petting, grooming, throwing toys, and feeding—provides bilateral upper extremity engagement that may benefit CBS patients with asymmetric motor involvement. The purposeful nature of these interactions may improve compliance compared to rote exercise.

Maintaining Physical Activity:

Progressive neurological conditions lead to declining physical activity, which in turn accelerates deconditioning. An animal companion provides daily motivation for physical activity that may not otherwise occur. Even modest daily walks with a dog can help maintain cardiovascular fitness and joint mobility.

4.2 Cognitive Benefits

Attention and Engagement:

Animal interactions require attention and engagement, providing cognitive stimulation in a naturalistic, non-threatening context. For CBS/PSP patients with [cognitive impairment](/mechanisms/cognitive-decline-neurodegeneration), this engagement may help maintain attention capacity and provide cognitive exercise[@bower2019].

Communication:

For CBS patients with language difficulties, animals provide a non-verbal focus for communication. Patients can talk about the animal, direct comments to the animal, or simply enjoy the company without the pressure of complex social conversation.

Memory:

Caring for an animal involves routines (feeding, medication times) that can serve as memory aids. The predictability of animal care schedules may support executive function in patients with frontal/executive impairment common in PSP.

4.3 Emotional Wellbeing Benefits

Anxiety Reduction:

The presence of animals has consistent anxiolytic effects that may be particularly valuable for CBS/PSP patients experiencing anxiety related to their diagnosis, prognosis, or functional limitations[@santaniello2020]. The non-judgmental nature of animal interaction provides a sense of safety.

Depression Management:

Animal companionship provides purpose and routine that can combat the depressive symptoms common in progressive neurological conditions. The unconditional positive regard provided by animals may be especially meaningful for patients experiencing social rejection or relationship changes due to their disease.

Identity and Self-Esteem:

For patients whose identity has been affected by neurological disability, the role of animal caregiver can provide a positive identity that is not centered on illness or disability. This can support self-esteem and psychological resilience.

5. Service Dog Programs and Training

5.1 Major Service Dog Organizations

Several organizations provide service dogs specifically trained for mobility and neurological conditions:

Application Process:

5.2 Custom Training Options

For patients who already own dogs or wish to pursue custom training, professional trainers can train existing pets to perform specific tasks. This option may be particularly relevant for patients in later disease stages who have established bonds with existing pets.

Task-Specific Training:

Trainers can be hired to teach specific tasks relevant to CBS/PSP:

• Balance support during walking
• Retrieval of dropped items
• Alerting to falls or medical events
• Providing deep pressure during anxiety episodes

6. Certification Requirements

6.1 Service Dog Certification

Service dogs in the United States are not required to be certified or registered under federal law. The Americans with Disabilities Act (ADA) defines a service dog as "a dog that is individually trained to do work or perform tasks for a person with a disability." No specific certification is legally required[@us].

However, many organizations and states maintain voluntary certification programs that can facilitate public access and provide verification of training standards. Common certifications include:

• Assistance Dogs International (ADI) accreditation
• International Association of Service Dog Professionals (IASDP) certification
• State-specific service dog registries

6.2 Therapy Animal Certification

Therapy animals typically require certification through organizations that evaluate the animal's temperament, obedience, and suitability for healthcare settings. Common certifying organizations include:

• [Therapy Dogs International (TDI)](https://www.tdi-inc.org/)
• [Pet Partners](https://petpartners.org/)
• [Alliance of Therapy Dogs](https://www.therapydogs.com/)

• Basic obedience training (sit, stay, come, heel)
• Temperament evaluation (reaction to noise, crowds, medical equipment)
• Health verification
• Handler training
• Observation in healthcare setting

6.3 Emotional Support Animal Documentation

ESAs require a letter from a licensed mental health professional (psychologist, psychiatrist, licensed clinical social worker, or physician) stating that the patient has a qualifying mental health condition and that the ESA provides therapeutic benefit[@fair].

7. Cost Considerations

7.1 Service Dog Costs

Free Programs:

Major service dog organizations provide dogs at no cost to qualifying individuals. However, these programs have extensive wait times (often 2+ years) and limited availability.

Fee-Based Programs:

Some organizations charge fees ranging from $5,000 to $25,000 for service dog training. These programs often have shorter wait times and may provide more personalized matching.

Ongoing Costs:

7.2 Therapy Animal Costs

Facility-Based Programs:

Many healthcare facilities and rehabilitation centers offer animal-assisted therapy at no direct cost to patients. These programs are typically funded through institutional budgets or grants.

Private Visits:

Private therapy animal visits can range from $50-$150 per session, depending on the handler's rates and travel requirements.

7.3 Emotional Support Animals

Costs for ESAs are primarily veterinary and care costs, similar to pet ownership. If a patient already owns a pet that provides emotional support, no additional cost is required beyond standard pet care.

7.4 Financial Assistance

Several resources may help offset costs:

• Flexible Spending Accounts (FSAs) may cover service dog expenses with proper documentation
• Some veterans' benefits cover service dog costs
• Charitable organizations occasionally provide grants for service dog acquisition
• Pet insurance can help manage veterinary costs

8. Practical Recommendations

8.1 For Patients Considering Animal-Assisted Interventions

Early Implementation:

Given the progressive nature of [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy), patients should consider animal-assisted interventions early in the disease course. This allows:

• Time to complete application processes and wait lists
• Ability to participate meaningfully in handler training
• Maximum benefit from animal partnership during less impaired years

Patients should honestly assess their ability to care for an animal:

• Can you walk and manage the animal safely?
• Can you afford ongoing care costs?
• Do you have caregiver support for days when you cannot provide care?
• Is your housing suitable for an animal?

For patients who cannot commit to service dog ownership, alternatives include:

• Therapy animal visits at rehabilitation facilities
• Volunteering at animal shelters (provides animal interaction with built-in support)
• Regular visits with family or friend's pets

8.2 For Caregivers

Caregivers play essential roles in supporting animal-assisted interventions:

Service Dog Care:

• Ensure the dog receives adequate exercise and care on days when the patient cannot
• Maintain veterinary care and grooming schedules
• Support training consistency
• Monitor the animal's wellbeing as disease progresses

• Supervise all animal interactions, especially if the patient has balance problems
• Ensure the animal does not create fall hazards
• Monitor for signs of stress in both patient and animal
• Consider how the animal will be managed as disease progresses

8.3 Integration with Treatment Plans

Animal-assisted interventions should be integrated into comprehensive treatment plans:

9. Conclusion

Animal-assisted interventions offer valuable complementary support for [CBS](/diseases/corticobasal-degeneration) and [PSP](/diseases/progressive-supranuclear-palsy) patients, addressing motor, cognitive, and emotional domains that are central to quality of life in these progressive conditions. While evidence specifically from CBS/PSP populations remains limited, the substantial evidence base from [Parkinson's disease](/diseases/parkinsons-disease) and the mechanistic rationale support the integration of these interventions into comprehensive care plans.

Service dogs, therapy animals, and emotional support animals each offer distinct benefits that can be matched to individual patient needs, disease stage, and personal circumstances. The costs—financial and in terms of care responsibility—are significant but may be offset by the profound benefits these partnerships provide.

For the CBS/PSP patient in this treatment plan, animal-assisted interventions represent a meaningful addition to the comprehensive therapeutic approach. Early consideration and planning can maximize the benefits of these interventions throughout the disease trajectory.

References

See Also

Related Hypotheses:

• [Bacterial Enzyme-Mediated Dopamine Precursor Synthesis](/hypotheses/h-7bb47d7a)
• [Purinergic Signaling Polarization Control](/hypotheses/h-0758b337)
• [Mechanosensitive Ion Channel Reprogramming](/hypotheses/h-db6aa4b1)
• [Lipid Droplet Dynamics as Phenotype Switches](/hypotheses/h-7d4a24d3)
• [HCN1-Mediated Resonance Frequency Stabilization Therapy](/hypotheses/h-d40d2659)

• [4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005)

• [N-of-1 Clinical Trial Design for CBS/PSP](/experiment/exp-wiki-experiments-n-of-1-clinical-trial-cbs-psp)
• [Brainstem Circuit Modulation for PSP](/experiment/exp-wiki-experiments-brainstem-circuit-modulation-psp)
• [Tau Spreading Network Mapping via Spatial Transcriptomics in PSP](/experiment/exp-wiki-experiments-tau-spreading-network-mapping-psp)

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Bacterial Enzyme-Mediated Dopamine Precursor Synthesis](/hypothesis/h-7bb47d7a) — <span style="color:#ffd54f;font-weight:600">0.44</span> · Target: TH, AADC
• [Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — <span style="color:#81c784;font-weight:600">0.74</span> · Target: P2RY1 and P2RX7
• [Mechanosensitive Ion Channel Reprogramming](/hypothesis/h-db6aa4b1) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: PIEZO1 and KCNK2
• [Lipid Droplet Dynamics as Phenotype Switches](/hypothesis/h-7d4a24d3) — <span style="color:#ffd54f;font-weight:600">0.57</span> · Target: DGAT1 and SOAT1
• [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style="color:#81c784;font-weight:600">0.79</span> · Target: CYP46A1
• [Gamma entrainment therapy to restore hippocampal-cortical synchrony](/hypothesis/h-bdbd2120) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SST
• [Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SMPD1
• [Purinergic P2Y12 Inverse Agonist Therapy](/hypothesis/h-f99ce4ca) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: P2RY12

• [4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) &#x1f504;
• [Astrocyte reactivity subtypes in neurodegeneration](/analysis/SDA-2026-04-01-gap-007) &#x1f504;
• [Lipid raft composition changes in synaptic neurodegeneration](/analysis/SDA-2026-04-01-gap-lipid-rafts-2026-04-01) &#x1f504;
• [TDP-43 phase separation therapeutics for ALS-FTD](/analysis/SDA-2026-04-01-gap-006) &#x1f504;
• [Synaptic pruning by microglia in early AD](/analysis/SDA-2026-04-01-gap-v2-691b42f1) &#x1f504;